Ignite Creation Date:
2024-05-06 @ 12:20 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03735875
Status:
TERMINATED
Last Update Posted:
2023-10-16
First Post:
2018-11-02
Brief Title:
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-02
First Submit QC Date:
November 7 2018
Study First Post Date:
2018-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2023-10-16
Last Update Post Date Type:
ACTUAL